Related references
Note: Only part of the references are listed.Metabolic reprogramming and the role of mitochondria in polycystic kidney disease
Christine Podrini et al.
CELLULAR SIGNALLING (2020)
Toward a better understanding of chronic kidney disease with complementary chromatographic methods hyphenated with mass spectrometry for improved polar metabolome coverage
Yoric Gagnebin et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study
Tae Ryom Oh et al.
SCIENTIFIC REPORTS (2019)
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Ki Wung Chung et al.
CELL METABOLISM (2019)
Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate
Caroline C. Pelletier et al.
TOXINS (2019)
A scoring approach for multi-platform acquisition in metabolomics
Julian Pezzatti et al.
JOURNAL OF CHROMATOGRAPHY A (2019)
The copy number variation landscape of congenital anomalies of the kidney and urinary tract
Miguel Verbitsky et al.
NATURE GENETICS (2019)
Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
Shangfu Li et al.
METABOLITES (2019)
Uric acid in chronic kidney disease: the quest for causality continues
Carmine Zoccali et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Applications of metabolomics to study cancer metabolism
Akash K. Kaushik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
A review of validated biomarkers obtained through metabolomics
Angeles Lopez-Lopez et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment
Muhammed Khairujjaman Mazumder et al.
MEDICAL HYPOTHESES (2018)
Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection
Tatiana N. Tarasenko et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS
S. Benito et al.
ANALYST (2018)
Untargeted metabolomics: an overview of its usefulness and future potential in prenatal diagnosis
Ewa Parfieniuk et al.
EXPERT REVIEW OF PROTEOMICS (2018)
An overview of renal metabolomics
Sahir Kalim et al.
KIDNEY INTERNATIONAL (2017)
Metabolomics for clinical use and research in chronic kidney disease
Berthold Hocher et al.
NATURE REVIEWS NEPHROLOGY (2017)
Metabolomic Alterations Associated with Cause of CKD
Morgan E. Grams et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
Monika A. Niewczas et al.
DIABETES CARE (2017)
A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population
Peggy Sekula et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
RENAL FIBROSIS IN 2015 Understanding the mechanisms of kidney fibrosis
Dong Zhou et al.
NATURE REVIEWS NEPHROLOGY (2016)
Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
Maria Giulia Battelli et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Renal dysplasia in the neonate
Yu L. Phua et al.
CURRENT OPINION IN PEDIATRICS (2016)
Regulation of uric acid metabolism and excretion
Jessica Maiuolo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
John R. Ussher et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity
Daniela A. Braun et al.
KIDNEY INTERNATIONAL (2016)
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Q. Qu et al.
CELL DEATH & DISEASE (2016)
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
Catharina Missailidis et al.
PLOS ONE (2016)
Identification of key metabolic changes in renal interstitial fibrosis rats using metabonomics and pharmacology
Liangcai Zhao et al.
SCIENTIFIC REPORTS (2016)
Renal systems biology of patients with systemic inflammatory response syndrome
Ephraim L. Tsalik et al.
KIDNEY INTERNATIONAL (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
Anti-hyperuricemic and nephroprotective effects of Rhizoma Dioscoreae septemlobae extracts and its main component dioscin via regulation of mOAT1, mURAT1 and mOCT2 in hypertensive mice
Junxia Su et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Emily G. Armitage et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
Monika A. Niewczas et al.
KIDNEY INTERNATIONAL (2014)
Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE
Ying-Yong Zhao et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Eugene P. Rhee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Uric acid and chronic kidney disease: which is chasing which?
Richard J. Johnson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome
Kunal Chaudhary et al.
CARDIORENAL MEDICINE (2013)
Metabolomics and Cardiovascular Biomarker Discovery
Eugene P. Rhee et al.
CLINICAL CHEMISTRY (2012)
A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics/metabolomics
Helen G. Gika et al.
BIOANALYSIS (2012)
Renal Mitochondrial Cytopathies
Francesco Emma et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2011)
Health Consequences of Catabolic Synthesis of Hippuric Acid in Humans
Ronald W. Pero
CURRENT CLINICAL PHARMACOLOGY (2010)
Mitochondrial DNA deletion in a girl with Fanconi's syndrome
Kam Ming Au et al.
PEDIATRIC NEPHROLOGY (2007)
Prevalence of mutations in renal developmental genes in children with renal hypodysplasia:: Results of the ESCAPE study
Stefanie Weber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Biochemical validation of a rat model for polycystic kidney disease: Comparison of guanidino compound profile with the human condition
A. Torremans et al.
KIDNEY INTERNATIONAL (2006)
Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats
T Deguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Trimethylamine: Metabolic, pharmacokinetic and safety aspects
MA Bain et al.
CURRENT DRUG METABOLISM (2005)
A boy with mitochondrial disease: asymptomatic proteinuria without neuromyopathy
Y Ueda et al.
PEDIATRIC NEPHROLOGY (2004)
Nitric oxide in uremia: Effects of several potentially toxic guanidino compounds
PP De Deyn et al.
KIDNEY INTERNATIONAL (2003)
Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria
BC Schwahn et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Share Paper
